EGFR (T790M, C797S) (del746-750) Kinase Assay Kit

Catalog #
78595
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The EGFR (T790M, C797S) (del746-750) Kinase Assay Kit is designed to measure the kinase activity of mutant EGFR (T790M, C797S) (del746-750) for screening and profiling applications using Kinase-Glo Max as a detection reagent. The assay kit comes in a convenient 96-well format, with enough purified recombinant EGFR (T790M, C797S) (del746-750) kinase, kinase substrate, ATP and kinase assay buffer for 100 enzyme reactions.

Need us to run inhibitor screens or profile your compounds against EGFR (T790M, C797S) (del746-750)? Check out our Kinase Screening Services.

Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Supplied As
The EGFR (T790M, C797S) (del746-750) Kinase Assay Kit comes in a convenient 96-well format, with enough purified recombinant EGFR (T790M, C797S) (del746-750) kinase, kinase substrate, ATP and kinase assay buffer for 100 enzyme reactions.
Materials Required But Not Supplied
  • Kinase-Glo MAX Kinase Assay
  • Microplate reader capable of reading luminescence
  • Adjustable micropipettor and sterile tips
  • 30°C incubator 
Format
Catalog # Name Amount Storage
100187 EGFR (T790M, C797S) (del746-750)* 2 µg -80°C
79334 5X Kinase Assay Buffer 1  1.5 ml -20°C
79686 ATP (500 µM) 100 µl -20°C
40217 PTK substrate Poly (Glu:Tyr: 4:1) (10 mg/ml) 100 µl -20°C
79696 96-well plate, white 1 Room Temp.

*The concentration of the protein is lot-specific and will be indicated on the tube

UniProt #
P00533
Background

The EGFR (epidermal growth factor receptor), also known as ErbB-1 and HER1, is a cell surface tyrosine kinase receptor belonging to the epidermal growth factor receptor family. Overexpression and/or hyperactivation of EGFR kinase is associated with several human cancers such as lung, glioblastoma, and epithelial tumors of the neck and head. This increased activity of EGFR has led to the development of anticancer therapeutics targeting EGFR. However, d746-750, T790M, and C797S mutations in EGFR can cause resistance to known EGFR inhibitors, requiring the development of next generation mutant-selective inhibitors.